Earnings And Financial PerformanceWELL Health Technologies Corp. beat expectations for the second quarter, with revenue up 57% year-over-year and adjusted EBITDA up 231% year-over-year, both beating estimates and consensus.
Financing And CapitalWELL has C$98.9M in cash and positive free cash flow, indicating it can fund organic growth without needing additional capital.
Growth And ExpansionEstimated revenue for 2025 and 2026 is expected to be C$1.41B and C$1.50B, showing significant growth over previous years.